Comparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Diabetes Mellitus
Interventions
BIOLOGICAL

30% Regular Insulin Human Neutral and 70%Isophane Insulin

Total Dose per subject is 0.4 IU/Kg given subcutaneously.

BIOLOGICAL

Novolin 70/30

Total Dose per subject is 0.4IU/Kg given Subcutaneously.

Trial Locations (1)

91911

Profil Institute for Clinical Research, Chula Vista

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Wockhardt

INDUSTRY